All stocks / VNOV
VitaNova Life Sciences Corp VNOV
VitaNova Life Sciences (VNOV): no warning signs from our rules in the last 12 months and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- VITANOVA LIFE SCIENCES CORP
- Market tier
- OTC Pink Current
- Trading status
- Active
- Last trade
- Nov 13
The financial report, and what it means
Annual figures to 2026-04-30- Revenue
- $3,025,538
- Net loss
- ($37,304)
It spends more than it earns
Under strainCustomers paid it $3 million in the year. It lost $37,304. For every $1 that came in, about $1.01 went out.
- Cash and cash equivalents
- $1,597,217
- Net cash from operating activities
- $814,407
The business brings in cash
SteadyDay-to-day business added $814,407 in cash over the year. It had $1.6 million in the bank.
- Total assets
- $2,446,561
- Total liabilities
- $395,781
It owns more than it owes
SteadyEverything the company owns adds up to $2.4 million. Its debts and unpaid bills add up to $395,781. That is about $0.16 owed for every $1 owned.
What this adds up to
1 of 3 checks show strain. It spends more than it earns. These are facts from the company's own reports, not a recommendation.
Signals
Estimated float about 8,337,454 shares as of 2026-09-14: 8,337,454 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about VNOV
Does VNOV file reports with the SEC?
Yes. VitaNova Life Sciences files with the SEC under company number 0001699709. The most recent filing we hold is a 10-Q dated 2026-09-14.
Source recordHow many VNOV shares are outstanding?
8,337,454 shares as of 2026-09-14, as reported to the SEC.
Source recordHas VNOV filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.
Is VitaNova Life Sciences making money?
Customers paid it $3 million in the year. It lost $37,304. For every $1 that came in, about $1.01 went out. (Annual figures to 2026-04-30. Facts from the company's own report, not a recommendation.)
Source record